The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
Open accessAbstract
Laboratory animal studies are used in a wide range of human health related research areas, such as basic biomedical research, drug research, experimental surgery and environmental health. The results of these studies can be used to inform decisions regarding clinical research in humans, for example the decision to proceed to clinical trials. If the research question relates to potential harms with no expectation of benefit (e.g., toxicology), studies in experimental animals may provide the only relevant or controlled data and directly inform clinical management decisions. Systematic reviews and meta-analyses are important tools to provide robust and informative evidence summaries of these animal studies. Rating how certain we are about the evidence could provide important information about the translational probability of findings in experimental animal studies to clinical practice and probably improve it. Evidence summaries and certainty in the evidence ratings could also be used (1) to support selection of interventions with best therapeutic potential to be tested in clinical trials, (2) to justify a regulatory decision limiting human exposure (to drug or toxin), or to (3) support decisions on the utility of further animal experiments. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach is the most widely used framework to rate the certainty in the evidence and strength of health care recommendations. Here we present how the GRADE approach could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions. We also discuss the methodological challenges that we identified, and for which further work is needed. Examples are defining the importance of consistency within and across animal species and using GRADE's indirectness domain as a tool to predict translation from animal models to humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering the difference and the leading clinical research, the SYRCLE group developed a framework definition of preclinical PICO, where ‘Population’ includes animal species and strain and any method of inducing a disease model, and several outcomes can be considered [8].”
From PICO entity extraction for preclinical animal literature. (2022) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Self-citationGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 1×
“The optimal application of GRADE requires an up-to-date and well-conducted SR of animal studies [18, 25].”
MethodSelf-citationImproving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
SYRCLE’s risk of bias tool for animal studies
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-43 · Cited by 4,415 · cited 2×
“In the probiotics for pancreatitis example, risk of bias was assessed with SYRCLE’s risk of bias tool [4].”
MethodSelf-citation
Research works printed but not linked: 4
- RB de Vries, 2014, Updated version of the Embase search filter for animal studies, Lab Anim, 48, 88
- P Alonso-Coello, GRADE Evidence to Decision frameworks: 1. Introduction, BMJ
- P Alonso-Coello, GRADE Evidence to Decision frameworks: 2. Clinical practice guidelines, BMJ
- HJ Schunemann, 2012, [Diagnostic accuracy and linked evidence—testing the chain], Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 106, 153
Cited by
Items 101–174 of 174
Cai, Z. M., Wang, Y., Hu, S., Yuan, Q., Liu, J., Luo, C., Jiang, L., & Huang, Y. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-024-03781-9 · Cited by 4
“In addition, studies were graded for evidence using the Grading of Recommendations Assessment, Devel - opment and Evaluation (GRADE) [ 29 ].”
Campos-González, N., Gómez‐Salazar, J. A., Cerón‐García, A., Lorenzo, J. M., Santos, E. M., Campagnol, P. C. B., & Sosa‐Morales, M. E. (2023) · Food Reviews International · doi:10.1080/87559129.2023.2228001 · Cited by 3
“[101 ] The available in vivo studies in meat and meat products focus primarily on evaluating the functionality of bioactive peptides derived from plants or animal residues.”
BackgroundWrangstål, L., Pigg, M., Almutairi, N., & Fransson, H. (2023) · International Endodontic Journal · doi:10.1111/iej.14011 · Cited by 3
Siafis, S., Nomura, N., Schneider‐Thoma, J., Bighelli, I., Bannach‐Brown, A., Ramage, F. J., Tinsdeall, F., Mantas, I., Jauhar, S., Natesan, S., et al. (2024) · F1000Research · doi:10.12688/f1000research.155356.1 · Cited by 3
Self-citationBeleva, E., Diukendjieva, A., Pajeva, I. K., & Tsakovska, I. (2025) · JMIR Research Protocols · doi:10.2196/66197 · Cited by 2
Hundscheid, T. M., Amodeo, I., Cavallaro, G., Hooijmans, C. R., Bartos̆, F., & Villamor, E. (2025) · Biomedicines · doi:10.3390/biomedicines13092274 · Cited by 2
“This approach can also highlight gaps in existing research, thereby guiding future studies to address these deficiencies [57,58].”
Self-citationPuspita, R. M., Agustiningsih, D., & Purwanti, N. (2026) · Physiology International · doi:10.1556/2060.2026.00710 · Cited by 2
Straccia, M., Azilagbetor, D. M., Camp, C., Ferreira, G. S., García-Bermejo, M. L., Gastaldello, A., Gurusamy, K. S., Pappalardo, F., Ritskes-Hoitinga, M. J., Rossi, F., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08604-1 · Cited by 2
“Other instruments generate semi-quantitative structured judgements, such as colour-coded matrices, certainty ratings, domain concern ratings, or annotated mechanistic pathways; examples include AMQA [22], RAA [23], GRADE4Animals [24], and PATH [25].”
InfluentialSelf-citationKim, M., Steffensen, I., Miguel, R. T. D., Babic, T., Johnson, A. D., Potts, R. J., & Junker, C. S. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-1710 · Cited by 5
“…approach to evaluate certainty of evidence—provides a systematic, transparent and explicit framework for assessing strength of clinical evidence; a modified version of the GRADE tool to rate the certainty and SOE of preclinical (animal) studies was considered for use in this systematic review (31).”
MethodMatsuyama, T., Ohta, B., Watanabe, M., & Kitamura, T. (2025) · Critical Care · doi:10.1186/s13054-024-05235-0 · Cited by 2
“However, these theoretical benefits observed in animal models have not consistently translated into significant clinical improvements in human studies [13, 32].”
Louka, P., Ferreira, N. B., & Sophocleous, A. (2025) · Biomedicines · doi:10.3390/biomedicines13051048 · Cited by 2
“Therefore, any interpretation should be carried out with a degree of caution.”
InfluentialDuieb, O., Boumlah, S., Laboudi, M., Elhessni, A., & Mesfioui, A. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100259 · Cited by 3
Learning from Principles of Evidence-Based Medicine to Optimize Nonclinical Research Practices
Lefevre, I. A., & Balice‐Gordon, R. J. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_276 · Cited by 4
Hooijmans, C. R., Buijs, M., Struijs, F., Som, T., Karim, N., Scheffer, G., & Malagon, I. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-35052-4 · Cited by 6
Self-citationPreclinical models of maternal asthma and progeny outcomes: a scoping review
Robinson, J. L., Gatford, K. L., Bailey, D., Roff, A. J., Clifton, V. L., Morrison, J. L., & Stark, M. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0174-2023 · Cited by 2
“The search strings were developed by a well published research group in this area, having done extensive work on systematic searching and assessment of animal models [44 – 46, 94, 95].”
Usta, S. N., Keskin, C., Pirimoğlu, B., & Aksoy, A. (2024) · Australian Endodontic Journal · doi:10.1111/aej.12873 · Cited by 1
The renal baroreflex: A systematic review and meta‐analysis in healthy and hypertensive animals
van Ochten, M., Fathi, W. E., Bovee, E. M. E., Spaanderman, M. E. A., Hooijmans, C. R., & van Drongelen, J. (2025) · Physiological Reports · doi:10.14814/phy2.70547 · Cited by 1
“It is important, however, to be aware that, due to the explorative nature of experimental animal studies, heterogeneity is expected and sometimes even de-liberately introduced (Hooijmans et al., 2018).”
Self-citationEffect of Statins on Wound Healing. A Systematic Review and Meta‐Analysis of Preclinical Evidence
Pachano-Bravo, A., Ganesan, O., Mueller, S., & Orgill, D. P. (2026) · Wound Repair and Regeneration · doi:10.1111/wrr.70133 · Cited by 1
“Collectively, these factors contribute to the substantial heterogeneity in our findings and highlight the need for improved reporting standards and methodological consistency in future preclinical research [23, 51, 54].”
Xiao, Y., 韩倩楠, Dong, Z., Yang, X., Xu, Z., Hu, K., Xuan, Z., Liang, G., Jiang, W., Peng, Y., et al. (2026) · Antioxidants · doi:10.3390/antiox15080980 · Cited by 1
“Because GRADE was originally developed primarily for clinical evidence, its domains were adapted to the characteristics of animal experimental research, with reference to methodological guidance on applying GRADE to preclinical animal evidence [27].”
van Rhijn-Brouwer, F. C. C.-C., Vernooij, R. W. M., Wever, K. E., Schilt, I., Fledderus, J. O., Verhaar, M. C., & Gremmels, H. (2021) · BMJ Open Science · doi:10.1136/bmjos-2021-100209 · Cited by 1
“11 Inclusion criteria Study population We will include in vivo studies in animals that underwent permanent femoral artery ligation or banding in one limb.”
Self-citationDigital modeling of critical conditions after metacarpophalangeal joint replacement
Николаенко, А. Н., vanov, V. V., Doroganov, S. O., Bukaty, A. S., Zgirsky, D. O., & Isaykin, P. Y. (2023) · Genij Ortopedii · doi:10.18019/1028-4427-2023-29-2-148-154 · Cited by 1
Preclinical Evidence Synthesis Facilitates Open Science
Bilynsky, C. (2024) · Journal of Science Policy & Governance · doi:10.38126/jspg230202 · Cited by 1
“Some researchers have even developed frameworks to guide the analysis of animal study systematic reviews, with the aim of reducing research waste and enhancing translational ef�icacy (Hooijmans et al. 2018).”
BackgroundSuerte, A. C. C., Liddle, L. J., Abrahart, A. H., Khiabani, E., & Colbourne, F. (2024) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2024.0012 · Cited by 2
“Measures of certainty, including publication bias, study limitations, and consistency of fi ndings across studies, were assessed (Hooijmans et al., 2018; Page et al., 2021).”
Rodgers, J. B., & Ritskes-Hoitinga, M. J. (2021) · Laboratory animal science and medicine · doi:10.1007/978-3-030-66147-2_10 · Cited by 1
Self-citationPurcell, E., Nguyen, T., Smith, M. J., Penny, T. R., Paton, M. C. B., Zhou, L., Jenkin, G., Miller, S., McDonald, C., & Malhotra, A. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.20.513105 · Cited by 1
“The overall certainty of results was determined as low according to the GRADE tool adapted for preclinical studies.[20]”
MethodInfluentialFarquhar-Smith, P. W., & Gordon-Williams, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735799554.793571725
Reynolds, P. S. (2023) · Wiley eBooks · doi:10.1002/9781119800002.ch4 · Cited by 2
Omega-3 fatty acids as a treatment option in periodontitis: Systematic review of preclinical studies
Непрелюк, О. А., Ирза, О. Л., & Kriventsov, M. A. (2024) · Nutrition and Health · doi:10.1177/02601060241284694 · Cited by 2
“Also, using the modi fi ed Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for pre-clinical studies (Hooijmans et al., 2018; Wei et al., 2016), the quality of evidence of the retrieved data was assessed.”
Ramos-Rojas, J. T., Peña, J., Pinto-Díaz, C. A., Veloso, V., Gabriel Rada, G., & Molina-León, H. F. (2024) · medRxiv · doi:10.1101/2024.02.22.24303207
Hwang, H. J., Choi, G. J., Choi, Y. S., Kim, B. G., & Kang, H. (2025) · Medicina · doi:10.3390/medicina61111933
“The certainty of evidence for each outcome was assessed according to the framework proposed by Hooijmans et al. [23], which adapts GRADE domains to preclinical animal studies.”
Lee, J., Lee, D., & Kang, H. (2025) · Medicina · doi:10.3390/medicina61122215
“The certainty of evidence for each outcome was evaluated using the framework proposed by Hooijmans et al. [26], which adapts the GRADE approach for use in preclinical animal research.”
Jansson, P. M., Lynggaard, C. D., Carlander, A. F., Jensen, S. B., Follin, B., Hoeeg, C., Kousholt, B. S., Larsen, R. T., Grønhøj, C., Jakobsen, K. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19613615
Jansson, P. M., Lynggaard, C. D., Carlander, A. F., Jensen, S. B., Follin, B., Hoeeg, C., Kousholt, B. S., Larsen, R. T., Grønhøj, C., Jakobsen, K. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19613618
de Souza, T. F., Martins, M. L., Magno, M. B., Maia, L. C., & Fonseca‐Gonçalves, A. (2026) · Maternal and Child Health Journal · doi:10.1007/s10995-025-04199-z
de Best, R. F., Coppieters, M. W., Bozis, C., Ziesemer, K. A., Hooijmans, C. R., & Scholten-Peeters, G. G. M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1700494
Self-citationKung, T. F. C., Suerte, A. C. C., Khiabani, E., Parranto, M. R., Arnott, S. G., Kalisvaart, A. C. J., Nakagawa, S., Klahr, A. C., & Colbourne, F. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00828-6 · Cited by 1
“This pre-clinical meta-analysis provides an update of the literature on estrogen and progesterone in AIS (most recent meta-analyses in 2014 [6] and 2013 [5], respectively) using statistically more rigorous techniques [20–22] and evidence certainty grading [22].”
InfluentialBelenki, D., Baaken, D., Meyer, F. B., & Kühne, J. (2026) · Environment International · doi:10.1016/j.envint.2026.110154
Rationale for a narrative approach in assessing RF-EMF in animal cancer studies
Mevissen, M., Ducray, A., Ward, J. M., KOPP-SCHNEIDER, A., Wood, A., Rivero, T. M., & Straíf, K. (2026) · Environment International · doi:10.1016/j.envint.2026.110153
Qu, G., Bi, Y., Wang, L., Xu, L., Zhang, Y., Ma, Y., Tian, C., & Zhang, Z. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1701536
“The certainty of evidence for each main outcome was assessed using the GRADE approach adapted for preclinical animal intervention studies (Hooijmans et al., 2018).”
Lohse, S. (2026) · European Journal for Philosophy of Science · doi:10.1007/s13194-026-00727-y · Cited by 2
“…to hardly play a role in the replication discourse in preclinical animal research – this is also reflected to some extent in the criteria checklists used in quality assessment tools of meta-animal research (Gurusamy et al., 2021 ; Hooijmans, Rovers et al., 2014 ; Hooijmans, Vries et al, 2018 ).”
Wang, Y., Wang, Q., Xie, H., Liu, X., Ju, Y., Liu, X., & Sun, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1806181
“The certainty of evidence was assessed using a modified Grading of Recommendations Assessment Development and Evaluation (GRADE) approach developed for systematic reviews of preclinical studies (Hooijmans et al., 2018).”
Can a DNA vaccine protect against Chagas disease? A systematic review of preclinical studies
Khan, I. A., dos Santos, E. C., Novaes, R. D., Carvalho, R. P. R., & de Oliveira, L. L. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128654
Chiu, Y., Lai, S., Wu, S., Lai, H.-F., Wu, Y., & Tsai, T. Z. (2026) · Biomedicines · doi:10.3390/biomedicines14061285
“Because no formal adapted GRADE-like certainty assessment was performed, the present findings should be considered hypothesis-generating preclinical evidence with limited translational certainty rather than definitive therapeutic proof [63].”
Curcumin as a multi-target therapy for osteoarthritis in rats: a systematic review and meta-analysis
Liu, H., Ye, Z., Wu, C., Cai, C., Fang, H., & Wang, Q. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02287-2
“The assessment was also informed by recommendations for evaluating the certainty of evidence from animal studies (Hooijmans et al. 2018 ; Wei et al. 2016).”
Sonji, G. M., Sonji, N. M., & Katerji, A. E. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2700161
Mevissen, M., Ducray, A., Ward, J. M., Kopp‐Schneider, A., McNamee, J. P., Wood, A. W., Rivero, T. M., & Straíf, K. (2026) · Environment International · doi:10.1016/j.envint.2026.110368
Bone physiological adaptations to whole-body vibration in mouse models: A Systematic Review
Bonanni, R., Cariati, I., Caprioli, L., Romagnoli, C., Falvino, A., Edriss, S., Cifelli, P., D’Arcangelo, G., Padua, E., Tancredi, V., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353776
“This methodology has been proposed in recent years to improve the assessment of the translational potential and certainty of evidence derived from animal model studies [22].”
Ficus carica as an Antidiabetic Agent: Evidence from a Meta-analysis of In Vivo Studies
Darmawan, R., Humairah, I., Hassan, M., Munthe, E. A., Primartati, D. M., Fadillah, N., Linda, Permana, G. I., & Fatmariza, A. R. (2026) · Journal of Applied Pharmaceutical Science · doi:10.1177/22313354261461006
“The overall certainty of evidence across studies was assessed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) framework adapted for preclinical animal studies, as described by Hooijmans et al. (2018).”
Chen, F., Zhou, X., Niu, Z., Li, L., & Li, G. H. (2026) · BMC Immunology · doi:10.1186/s12865-026-00880-2
“The certainty of evidence for major outcomes was assessed using an adapted GRADE approach [22, 23]. of nasal rubbing, serum total IgE, OVA-specific IgE, eosinophil infiltration counts in nasal tissues, and levels of inflammatory cytokines such as IL-4 and IL-5.”
Hülsemann, M., Kniffert, S., Löwa, A., Baumgardt, M., Hönzke, K., Vallone, V. B. F., Drude, N., Stüdemann, T., Ali, A. S. M., Arroyo-Araujo, M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106392
“38,39 43 Achieving this requires transparent methodological reporting and harmonised standards as a foundation for cumulative evidence generation (Key Recommendations 2, 5 in Panel 1).”
Antoniazzi, C. T. D. D., Brito, H. A., Rodrigues, P., Fim, Y. V., Ruviaro, N. A., Machado, A. C., & Trevisan, G. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179210
Orzuna‐Orzuna, J. F., Godina-Rodríguez, J. E., Martínez, G. D. M., Silva, G. V., Razo-Ortíz, P. B., Galván, C. D., Sánchez-López, N., & Hernández-García, P. A. (2026) · Biology · doi:10.3390/biology15151288
“The PICO (Population, Intervention, Comparison, and Outcome) format proposed by Hooijmans et al. [25] was used to formulate the research question, which included the following components: lambs as the population (P), dietary supplementation with guanidinoacetic acid as the intervention (I), diets…”
Duan, H., Liu, Y., Kongpol, K., & Phanumartwiwath, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02366-4
“These uncertainties were reflected in the GRADE assess - ment, which rated the certainty of evidence as very low for all outcomes because of risk of bias, inconsistency, imprecision, indirectness, and possible publication bias (Hooijmans et al. 2018).”
Chandrashekar, S., Harikrishna, N., Banerjee, A., Lakshmi, C., V, Hegde, N. N., & Hegde, M. N. (2026) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2026.1871959
“Since all included studies were in vitro studies, the starting certainty was set as “Very Low” for all outcomes, consistent with the GRADE Working Group’s recommendations regarding initial certainty levels for different study designs in preclinical research (26).”
Chen, Y., Zhu, T., Li, M., Tan, T., & Cui, J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1893796
Teoh, B. K., Nguyen, T. T. H., Peddanna, K., Quach, T. V. B., Lin, J., & Chen, Y. (2026) · Brain Sciences · doi:10.3390/brainsci16090914
“…has been adapted for preclinical intervention studies, but methodological challenges remain when evaluating heterogeneous animal evidence, while OHAT is principally structured around defined exposure–health-outcome evidence and applies project-specific approaches to mechanistic evidence [108,109].”
Vázquez-Martínez, Y. E., Bautista–Martínez, Y., Granados–Rivera, L. D., Albarrán, M. R., Loredo‐Osti, J., Vargas‐Bello‐Pérez, E., & Orzuna‐Orzuna, J. F. (2026) · Ruminants · doi:10.3390/ruminants6030080
Tan, C., Zhou, X., Xie, Y., & Zhi, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1945663
“Certainty for each pooled outcome was assessed using an adapted GRADE framework for preclinical animal intervention studies (Hooijmans et al., 2018).”
Mohtashami, T., Aghayan, A. H., Masoudi, A., Atashi, A., Garmabi, B., Jamalpoor, Z., & Khaksari, M. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116478
Sahebnazar, E., Asadi, A., Hormati, A. H., Nasab, N. Y., Jafarnezhadgero, A., & Sacit, H. (2026) · Middle East Journal of Rehabilitation and Health Studies · doi:10.5812/mejrh-173000
Muñoz‐Carrillo, J. L., Gutiérrez-Coronado, O., Hernández, E. L., Hernández, R. G., Sabbagh, Y., Zamora-Aguilar, A. K., Cortés, N. R., Chávez-Ruvalcaba, F., Villalobos‐Gutiérrez, P. T., & Chávez-Ruvalcaba, M. I. (2026) · Pharmaceuticals · doi:10.3390/ph19091497
Wojtysiak, K., Ratka, Z., & Chłopaś‐Konowałek, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198492
“Certainty was evaluated using an adapted preclinical GRADE framework informed by Hooijmans et al. (2018) [14].”
Basic aspects in biomedical research methodology
Khattab, M. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45595-7.00003-0
Zhang, X., Guo, Y., Chen, L., Song, N., Yang, Y., Kong, J., Xu, H., Liu, Y., & Li, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1890021
“For preclinical evidence, particular attention was given to indirectness arising from animal-to-human translation (Hooijmans et al., 2018).”
Wang, Y., Wang, Q., Xie, H., Liu, X., Ju, Y., Liu, X., & Sun, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1818197
“The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for preclinical animal studies (Hooijmans et al., 2018).”
Li, A., 张熔熔, Li, Y., Fang, M., Li, C., Yang, H., Zhong, Z., & Zheng, C. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179407
Pistollato, F., Tripodi, I. J., Furtmann, F., Straccia, M., & Constantino, H. (2026) · NAM journal. · doi:10.1016/j.namjnl.2026.100146
Lazzara, V., Perri, A., Pandolfo, A., Pinto, P., Carlino, G., Grutta, S. L., Pace, E., Albano, G. D., & Malizia, V. (2026) · Marine Drugs · doi:10.3390/md24100358 · Cited by 1
“All 11 meta-analysed outcomes were rated as very low certainty because of recurrent risk-of-bias concerns, indirectness arising from animal models and surrogate outcomes [90], inconsistency or imprecision for several estimates, and suspected small-study effects where applicable.”
Wang, Z., Zhang, N., Ren, J., & Li, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1951582
“Each outcome started with a high level of certainty, with downgrading considered separately for risk of bias, inconsistency, indirectness, imprecision, and publication bias; no upgrading factors were applied (Hooijmans et al., 2018).”
Tudoraşcu, D. R., Vere, C. C., Petrescu, M., Ciurea, A.-M., Pana, R. C., Dan, A. O., Târtea, E. A., Greșiță, A., Hădăreanu, D.-R., Obleagă, C. V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209090
“The assessment of the level of confidence in the evidence followed the preclinical adaptation of the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach [52,53].”
Hernández-García, P. A., Godina-Rodríguez, J. E., Mata-Espinosa, M. Á., Orzuna‐Orzuna, J. F., de la Torre-Hernández, M. E., Sánchez-López, N., Razo-Ortíz, P. B., & Galván, C. D. (2026) · Ruminants · doi:10.3390/ruminants6040091
Jiao, Y., Feng, Q., Ren, Y., Sun, J., Wu, R., Li, Q., Gao, J., Zhou, Z., Qiu, Q., Wang, Z., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1988968
Metadata
- Authors
- Hooijmans, C. R., de Vries, R. B. M., Ritskes-Hoitinga, M., Rovers, M. M., Leeflang, M. M., IntHout, J., Wever, K. E., Hooft, L., de Beer, H., Kuijpers, T., Macleod, M. R., Sena, E. S., ter Riet, G., Morgan, R. L., Thayer, K. A., Rooney, A. A., Guyatt, G. H., Schünemann, H. J., Langendam, M. W., & on behalf of the GRADE Working Group
- Affiliations
- Radboud University Medical Center (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- University Medical Center Utrecht (NL)
- Dutch College of General Practitioners (NL)
- University of Edinburgh (GB)
- McMaster University (CA)
- United States Department of Health and Human Services (US)
- Corresponding author
- Langendam, Miranda W.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-01-11
- Volume
- 13
- Issue
- 1
- Pages
- e0187271
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5764235
- OpenAlex
- W2784327403
- Cited by
- 176
- References
- 60
- Citations by year
- 2026: 45 · 2025: 23 · 2024: 22 · 2023: 17 · 2022: 24 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 4
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Ministerie van Volksgezondheid, Welzijn en Sport (321200)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- preclinical animal studies, GRADE, translational research, animal-to-human extrapolation, indirectness, toxicology, evidence-based medicine
- MeSH terms
- Animals, Decision Making, Delivery of Health Care, Humans, Evidence-Based Medicine, Models, Animal, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.